Dashboard
Manage Tickers

GNPXGenprex, Inc.

Nasdaq genprex.com


$ 2.55 $ -0.06 (-2.53 %)    

Wednesday, 15-May-2024 15:49:31 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 2.505
$ 2.51
$ 0.00 x 0
$ 0.00 x 0
$ 2.47 - $ 2.55
$ 2.09 - $ 42.40
44,985
na
5.26M
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-21-2023 06-30-2023 10-Q
5 05-22-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-26-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-17-2018 12-31-2017 10-K
27 11-27-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-genprex-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Genp...
05/15/2024 15:28:23

HC Wainwright & Co. analyst Yi Chen reiterates Genprex (NASDAQ:GNPX) with a Buy and maintains $10 price target.

genprex-administers-first-dose-in-acclaim-3-clinical-study-of-reqorsa-immunogene-therapy-combined-with-tecentriq-to-treat-small-cell-lung-cancer
Genprex Administers First Dose In Acclaim-...
05/14/2024 12:32:35

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ:GNPX), a clinical-stage gene therapy company focused on deve...

genprex-appoints-jose-a-moreno-toscano-as-chairman-of-the-board-of-directors
Genprex Appoints Jose A. Moreno Toscano As...
05/13/2024 12:39:57

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/26/2024 12:06:32

genprex-earlier-reported-preclinical-data-for-reqorsa-immunogene-therapy-and-nprl2-gene-therapy-for-lung-cancer
Genprex Earlier Reported Preclinical Data ...
04/09/2024 13:41:31

Compelling Data Validates the Potential of Reqorsa® Immunogene Therapy and the Oncoprex® Delivery System as Innovative Cancer T...

hc-wainwright--co-reiterates-buy-on-genprex-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Genp...
04/04/2024 10:33:39

HC Wainwright & Co. analyst Yi Chen reiterates Genprex (NASDAQ:GNPX) with a Buy and maintains $10 price target.

genprex-expands-clinical-trial-sites-for-acclaim-3-clinical-study-of-reqorsa-therapy-in-combination-with-tecentriq-for-small-cell-lung-cancer
Genprex Expands Clinical Trial Sites For A...
04/03/2024 12:32:28

 Multiple clinical trial sites to be opened under collaboration with large network of community-based oncology practices       ...

hc-wainwright--co-reiterates-buy-on-genprex-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Genp...
04/03/2024 10:23:53

HC Wainwright & Co. analyst Yi Chen reiterates Genprex (NASDAQ:GNPX) with a Buy and maintains $10 price target.

genprex-publishes-preclinical-data-with-nprl2-gene-therapy-using-oncoprex-delivery-system
Genprex Publishes Preclinical Data With NP...
04/02/2024 12:34:36

NPRL2 Gene Therapy Induces Anti-Tumor Activity in Anti-PD1 Resistant KRAS/STK11 Mutant Non-Small Cell Lung Cancer in a Humanize...

hc-wainwright--co-initiates-coverage-on-genprex-with-buy-rating-announces-price-target-of-10
HC Wainwright & Co. Initiates Coverage On ...
03/25/2024 10:21:30

HC Wainwright & Co. analyst Yi Chen initiates coverage on Genprex (NASDAQ:GNPX) with a Buy rating and announces Price Ta...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
03/19/2024 17:31:02

genprex-announces-65m-registered-direct-offering-priced-at-the-market-under-nasdaq-rules
Genprex Announces $6.5M Registered Direct ...
03/19/2024 12:38:57

genprex-receives-notice-of-patent-grant-for-korean-patent-claiming-reqorsa-immunogene-therapy-with-pd-1-and-pd-l1-antibodies-to-treat-cancers
Genprex Receives Notice Of Patent Grant Fo...
03/12/2024 13:03:09

why-united-natural-foods-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why United Natural Foods Shares Are Tradin...
03/06/2024 18:54:52

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

genprex-collaborators-to-present-preclinical-data-on-use-of-reqorsa-and-on-nprl2-gene-therapy-utilizing-non-viral-oncoprex-delivery-system-for-lung-cancers-at-2024-aacr-annual-meeting
Genprex Collaborators To Present Preclinic...
03/06/2024 13:36:39

Reqorsa® Immunogene Therapy May be a Potential Therapy for ALK-Positive Lung CancerREQORSA has Anti-Tumor Mechanisms that Targe...

genprex-expands-nonclinical-programs-through-sponsored-research-agreements-and-material-transfer-agreements-to-study-tusc2-and-nprl2-tumor-suppressor-genes
Genprex Expands Nonclinical Programs Throu...
02/07/2024 13:20:57

Reqorsa® Therapy May Be Potential Treatment for ALK-Positive Lung CancerThree Collaborators Selected to Present Positive Noncli...

Core News & Articles
Genprex Has Enrolled And Dosed The First P...
02/05/2024 12:36:10

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
02/02/2024 13:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
02/02/2024 00:50:04

dow-turns-lower-federal-reserve-keeps-rates-unchanged
Dow Turns Lower; Federal Reserve Keeps Rat...
01/31/2024 19:26:51

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 1.5% on Wednesday. The Dow traded...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION